Zhangzhou Pientzehuang Pharmaceutical Co Ltd banner

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 157.4 CNY -0.59% Market Closed
Market Cap: ¥95B

Profitability Summary

Zhangzhou Pientzehuang Pharmaceutical Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Margins Comparison
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
95B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
584.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
262.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
238.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.5B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
289.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.4B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
95B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
584.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
262.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
238.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.5B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
289.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.4B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett